CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that data presented at Digestive Disease Week (DDW) 2022 show ...
Provation serves thousands of hospitals, surgical facilities, anesthesia groups, and medical offices, including 43 of the top 50 U.S. hospitals for gastroenterology (GI) and GI surgery. Iterative ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that its artificial intelligence platforms will be featured in ...
Healthcare costs attributed to cancer treatments were roughly $84.8 billion in 2014 in the United States. Colonoscopies are performed once a decade for individuals over the age of fifty to monitor and ...
After chipping in to its last two venture funding rounds, Johnson & Johnson is taking an even bigger chance on Iterative Scopes. The startup, which spun out of MIT in 2017, is developing artificial ...
From a new chief medical officer to new FDA clearances, here are six Iterative Scopes updates Becker’s has reported on in 2022. 1. Iterative Scopes rebranded, changing its name to Iterative Health. 2.
In the past six months, the MIT artificial intelligence spinout Iterative Scopes raised $30 million in funding and secured European approval for its software to help spot the signs of colorectal ...
Artificial intelligence is increasingly shaking up the health care field — and, as evidenced by a new MIT spinout called Iterative Scopes, major pharmaceutical players are beginning to notice.
Iterative Scopes obtained $150 million in series B funding to develop its artificial intelligence-powered gastroenterology technology, the company said Jan. 19. The financing comes after the company ...
Iterative Scopes Inc. picked up $30 million in series A financing to advance artificial intelligence (AI)-powered precision medicine for gastroenterology. The money will be used to further develop the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results